[Federal Register Volume 61, Number 224 (Tuesday, November 19, 1996)]
[Notices]
[Page 58883]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-29583]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made a final finding of scientific misconduct in the 
following case:
    Eric Whitters, Ph.D., University of Oregon: Based upon an 
investigation conducted by the University of Oregon as well as Dr. 
Whitters' own admission, ORI found that Eric Whitters, Ph.D., former 
postdoctoral fellow, Institute of Molecular Biology at the University 
of Oregon, engaged in scientific misconduct by fabricating experimental 
results that involved the selective growth of yeast strains that he 
represented as having temperature-sensitive phenotypes. The research 
was supported in part by a grant from the National Institute of General 
Medical Sciences (NIGMS), National Institutes of Health (NIH).
    Dr. Whitters has accepted the ORI finding and has entered into a 
Voluntary Exclusion Agreement with ORI in which he has voluntarily 
agreed, for the three (3) year period beginning November 6, 1996, to 
exclude himself from:
    (1) any contracting or subcontracting with any agency of the United 
States Government and from eligibility for, or involvement in, 
nonprocurement transactions (e.g., grants and cooperative agreements) 
of the United States Government as defined in 45 CFR Part 76 (Debarment 
Regulations), and
    (2) serving in any advisory capacity to the Public Health Service 
(PHS), including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.
    The research at issue did not affect any published research and was 
not included in any grant application.

FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research 
Investigations, Office of Research Integrity, 5515 Security Lane, Suite 
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 96-29583 Filed 11-18-96; 8:45 am]
BILLING CODE 4160-17-P